139 related articles for article (PubMed ID: 38401018)
1. The potential therapeutic effect of melatonin in oxaliplatin combination therapy against chemoresistant colorectal cancer cells.
Dehghanzad M; Mohammadi M; Nejati M; Pouremamali F; Maroufi NF; Akbarzadeh M; Samadi N; Nouri M
Mol Biol Rep; 2024 Feb; 51(1):348. PubMed ID: 38401018
[TBL] [Abstract][Full Text] [Related]
2. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
3. Cancer Drug Resistance Reduction via Co-treatment with Oxaliplatin and Nitazoxanide: Targeting the ABC Transporters.
Hemmati-Dinarvand M; Mokhtari H; Alipourfard I; Beyrami Aghbash E; Kheirandish S; Khodadadian A; Seghatoleslam A
Curr Mol Med; 2023; 23(8):834-841. PubMed ID: 35996253
[TBL] [Abstract][Full Text] [Related]
4. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p.
Ghanbarian M; Afgar A; Yadegarazari R; Najafi R; Teimoori-Toolabi L
Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807
[TBL] [Abstract][Full Text] [Related]
5. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
6. Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations.
Hamed AR; Yahya SMM; Nabih HK
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1117-1128. PubMed ID: 36651944
[TBL] [Abstract][Full Text] [Related]
7. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
8. [Role of ubiquitin-specific peptidase 22 in multidrug resistance of colorectal cancer and its correlation with multidrug resistance gene P-gp].
Zhang L; Wang JY; Li X; Chen XY; Wu WX
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(48):3944-3949. PubMed ID: 34954996
[No Abstract] [Full Text] [Related]
9. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
[TBL] [Abstract][Full Text] [Related]
10. Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
Lee JH; Yoon YM; Han YS; Yun CW; Lee SH
Anticancer Res; 2018 Apr; 38(4):1993-2000. PubMed ID: 29599315
[TBL] [Abstract][Full Text] [Related]
11. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.
Lu WQ; Hu YY; Lin XP; Fan W
Oncotarget; 2017 Jul; 8(27):44171-44185. PubMed ID: 28498807
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
[TBL] [Abstract][Full Text] [Related]
16. Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer.
Sui H; Zhu HR; Wu J; Nikitin AY; Cai JF; Fan ZZ; Li Q
Chin J Integr Med; 2014 Aug; 20(8):610-7. PubMed ID: 23543356
[TBL] [Abstract][Full Text] [Related]
17. Intense endoplasmic reticulum stress (ERS) / IRE1α enhanced Oxaliplatin efficacy by decreased ABCC10 in colorectal cancer cells.
Liu X; Wu B; Chen H; Sun H; Guo X; Sun T; Zhou D; Yang S
BMC Cancer; 2022 Dec; 22(1):1369. PubMed ID: 36585626
[TBL] [Abstract][Full Text] [Related]
18. Casein Kinase 2α Augments Oxaliplatin Resistance in Colorectal Cancer Cells by Increasing ABCE1 Expression.
Yun CW; Lee JH; Lee SH
Anticancer Res; 2023 Jun; 43(6):2519-2525. PubMed ID: 37247928
[TBL] [Abstract][Full Text] [Related]
19. The Role of Cyanidin-3-
Kurter H; Basbinar Y; Ellidokuz H; Calibasi-Kocal G
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004099
[TBL] [Abstract][Full Text] [Related]
20. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.
Asadzadeh Z; Mansoori B; Mohammadi A; Kazemi T; Mokhtarzadeh A; Shanehbandi D; Hemmat N; Derakhshani A; Brunetti O; Safaei S; Aghajani M; Najafi S; Silvestris N; Baradaran B
Biomed Pharmacother; 2021 May; 137():111364. PubMed ID: 33592546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]